These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 24695297)
1. Cancer treatment: The killer within. Ledford H Nature; 2014 Apr; 508(7494):24-6. PubMed ID: 24695297 [No Abstract] [Full Text] [Related]
2. Cocktails for cancer with a measure of immunotherapy. Ledford H Nature; 2016 Apr; 532(7598):162-4. PubMed ID: 27075078 [No Abstract] [Full Text] [Related]
3. 'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations. Tran E; Robbins PF; Rosenberg SA Nat Immunol; 2017 Feb; 18(3):255-262. PubMed ID: 28198830 [TBL] [Abstract][Full Text] [Related]
4. The benefits of immunotherapy combinations. Schmidt C Nature; 2017 Dec; 552(7685):S67-S69. PubMed ID: 29293245 [No Abstract] [Full Text] [Related]
5. New checkpoint inhibitors ride the immunotherapy tsunami. Mullard A Nat Rev Drug Discov; 2013 Jul; 12(7):489-92. PubMed ID: 23812256 [No Abstract] [Full Text] [Related]
6. Old cancer drug gets fresh look. Ledford H Nature; 2014 May; 509(7502):541-2. PubMed ID: 24870520 [No Abstract] [Full Text] [Related]
8. Introduction: Cancer Immunology Special Issue-Immunotherapy. Kawakami Y Int Immunol; 2016 Jul; 28(7):317. PubMed ID: 27313100 [No Abstract] [Full Text] [Related]
9. Checkpoint inhibitors: outstanding efficacy but at what cost? Klastersky JA Curr Opin Oncol; 2016 Jul; 28(4):253. PubMed ID: 27163724 [No Abstract] [Full Text] [Related]
10. Immunotherapy of melanoma: present options and future promises. Rotte A; Bhandaru M; Zhou Y; McElwee KJ Cancer Metastasis Rev; 2015 Mar; 34(1):115-28. PubMed ID: 25589384 [TBL] [Abstract][Full Text] [Related]
11. The expanding role of immunotherapy. Martin-Liberal J; Ochoa de Olza M; Hierro C; Gros A; Rodon J; Tabernero J Cancer Treat Rev; 2017 Mar; 54():74-86. PubMed ID: 28231560 [TBL] [Abstract][Full Text] [Related]
12. Reversing T-cell Dysfunction and Exhaustion in Cancer. Zarour HM Clin Cancer Res; 2016 Apr; 22(8):1856-64. PubMed ID: 27084739 [TBL] [Abstract][Full Text] [Related]
13. Releasing the Brakes on Cancer Immunotherapy. Ribas A N Engl J Med; 2015 Oct; 373(16):1490-2. PubMed ID: 26348216 [No Abstract] [Full Text] [Related]
14. Cancer immunotherapy comes of age and looks for maturity. Finck A; Gill SI; June CH Nat Commun; 2020 Jul; 11(1):3325. PubMed ID: 32620755 [TBL] [Abstract][Full Text] [Related]
15. Current and Emerging Perspectives on Immunotherapy for Melanoma. Daud A Semin Oncol; 2015 Dec; 42 Suppl 3():S3-S11. PubMed ID: 26598057 [TBL] [Abstract][Full Text] [Related]
16. Breakthrough of the year 2013. Cancer immunotherapy. Couzin-Frankel J Science; 2013 Dec; 342(6165):1432-3. PubMed ID: 24357284 [No Abstract] [Full Text] [Related]
17. Clinical deployment of antibodies for treatment of melanoma. Curti BD; Urba WJ Mol Immunol; 2015 Oct; 67(2 Pt A):18-27. PubMed ID: 25746916 [TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibitors for Urologic Cancer: The Tip of the Iceberg? Powles T Eur Urol; 2015 Aug; 68(2):280-2. PubMed ID: 25800945 [No Abstract] [Full Text] [Related]